Miki C - Search Results

1

Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.

Saigusa S, Tanaka K, Toiyama Y, Yokoe T, Okugawa Y, Ioue Y, Miki C, Kusunoki M. Saigusa S, et al. Among authors: miki c. Ann Surg Oncol. 2009 Dec;16(12):3488-98. doi: 10.1245/s10434-009-0617-z. Ann Surg Oncol. 2009. PMID: 19657699

2

Nutritional status and cytokine-related protein breakdown in elderly patients with gastrointestinal malignancies.

Inoue Y, Miki C, Kusunoki M. Inoue Y, et al. Among authors: miki c. J Surg Oncol. 2004 May 1;86(2):91-8. doi: 10.1002/jso.20052. J Surg Oncol. 2004. PMID: 15112251

3

Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma.

Konishi N, Miki C, Yoshida T, Tanaka K, Toiyama Y, Kusunoki M. Konishi N, et al. Among authors: miki c. Oncology. 2005;68(2-3):138-45. doi: 10.1159/000086768. Epub 2005 Jul 4. Oncology. 2005. PMID: 16006751

4

The optimal schedule for 5-fluorouracil radiosensitization in colon cancer cell lines.

Ojima E, Inoue Y, Watanabe H, Hiro J, Toiyama Y, Miki C, Kusunoki M. Ojima E, et al. Among authors: miki c. Oncol Rep. 2006 Nov;16(5):1085-91. Oncol Rep. 2006. PMID: 17016597

5

Does preoperative chemo-radiotherapy enhance the expression of vascular endothelial growth factor in patients with rectal cancer?

Inoue Y, Ojima E, Watanabe H, Hiro J, Toiyama Y, Kobayashi M, Miki C, Kusunoki M. Inoue Y, et al. Among authors: miki c. Oncol Rep. 2007 Aug;18(2):369-75. Oncol Rep. 2007. PMID: 17611658

6

Serum immunosuppressive acidic protein reflects systemic deterioration of colorectal cancer patient condition.

Toiyama Y, Miki C, Inoue Y, Okugawa Y, Koike Y, Watanabe H, Yokoe T, Hiro J, Ojima E, Tanaka K, Kusunoki M. Toiyama Y, et al. Among authors: miki c. J Surg Oncol. 2008 Apr 1;97(5):404-8. doi: 10.1002/jso.20966. J Surg Oncol. 2008. PMID: 18181167

7

Alteration of the chemoresistant gene expression during chemotherapy for colon cancer: a molecular case report.

Toiyama Y, Inoue Y, Hiro J, Ojima E, Watanabe H, Miki C, Kusunoki M. Toiyama Y, et al. Among authors: miki c. Oncol Rep. 2008 Mar;19(3):755-9. Oncol Rep. 2008. PMID: 18288412

8

Soluble intercellular adhesion molecule-1 as a prognostic marker for stage II colorectal cancer patients.

Toiyama Y, Miki C, Inoue Y, Okugawa Y, Koike Y, Yokoe T, Tanaka K, Kusunoki M. Toiyama Y, et al. Among authors: miki c. Ann Surg Oncol. 2008 Jun;15(6):1617-24. doi: 10.1245/s10434-008-9874-5. Epub 2008 Mar 27. Ann Surg Oncol. 2008. PMID: 18368454 Clinical Trial.

9

Mechanism of resistance to chemoradiation in p53 mutant human colon cancer.

Hiro J, Inoue Y, Toiyama Y, Miki C, Kusunoki M. Hiro J, et al. Among authors: miki c. Int J Oncol. 2008 Jun;32(6):1305-10. doi: 10.3892/ijo_32_6_1305. Int J Oncol. 2008. PMID: 18497992

10

Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer.

Koike Y, Miki C, Okugawa Y, Yokoe T, Toiyama Y, Tanaka K, Inoue Y, Kusunoki M. Koike Y, et al. Among authors: miki c. J Surg Oncol. 2008 Dec 1;98(7):540-4. doi: 10.1002/jso.21154. J Surg Oncol. 2008. PMID: 18937231

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters